Skip to main content
. 2024 Nov 15;16(47):65319–65327. doi: 10.1021/acsami.4c14715

Figure 5.

Figure 5

(a) 1H and 19F MRI of PIBMAOAm-FSON-IR780 NPs with various concentrations. (b) In vivo 1H and 19F MRI images of 4T1 subcutaneous tumor-bearing BALB/c mice after intravenous (i.v.) injection with PIBMA-FSON-Cy7 polymer and PIBMAOAm-FSON-IR780 NPs, respectively, at different time intervals.